Objective Caregiving for children affects caregivers' lives in many significant ways. Stress of caregivers is understudied and under-reported. The objective was to examine how taking care of a child (<18 years old) affects health of caregivers with mostly typically developing children versus children with a medical condition as a first step toward developing a screener to identify caregivers who need additional supports. Methods Caregivers responded to PROMIS-29 and the University of Washington Caregiver Stress Scale (UW-CSS), a self-reported IRT-based item bank. For all scales, the general population score is 50. The samples included a community sample, and caregivers of children with Epileptic Encephalopathies (i.e., severe epilepsy), Muscular Dystrophy (MD) and Down Syndrome (DS). The clinical populations were selected because they represent different types of caregiving stress (e.g., mostly cognitive or physical challenges, or both). The mean scores were compared between the general population and clinical populations using t-tests.
Background
Fatigue is prevalent, severe and one of the most disabling symptoms in rheumatoid arthritis (RA). There is no standardized measure for its assessment nor data concerning the performance of PROMIS-Fatigue short forms (SFs) in people with RA. We evaluated the construct validity of 4-, 7-, and 8-item PROMIS-Fatigue SFs in RA patients across the range of disease activity. Methods Adult RA patients were recruited from an online arthritis patient community and an observational cohort drawing from three academic medical centers. Measures included PROMIS-Fatigue SFs (7a, 8a, 4a), other PROMIS measures of RA symptoms, and selected patient reported outcomes including RAND-36 Vitality, Fatigue NRS, and patient global assessment of disease activity. Clinical outcomes from the observational cohort included swollen and tender joint counts (28), physician global assessment, and the RA Clinical Disease Activity Index (CDAI). Results A total of 548 (200 online, 348 observational cohort) participants were included. PROMIS Fatigue SF scores spanned the measurement continuum and correlated highly with each other (r's ≥0.91) and other fatigue measures (r's ≥0.85). PROMIS-Fatigue SF scores were highly and inversely associated with Physical Function and Participation (r's -0.77 to -0.78), and moderately-highly and positively correlated with pain, sleep disturbance, anxiety, and depression (r's 0.60 to 0.75). PROMIS-Fatigue SF scores showed dose-response relationships across fatigue severity descriptors and CDAI categories. Conclusions These results provide new evidence supporting the construct validity of the 4, 7, and 8-item PROMIS-Fatigue SFs. The SFs capture fatigue across the spectrum of RA disease activity in diverse groups of individuals and should be considered for use as patient-centered assessments of RA disease control and treatment efficacy.
The objective of this study was to determine if PROMIS-CAT scoring varies between providers or with primary orthopaedic complaint for a given patient. Methods All patients presenting to an orthopaedic office at this institution complete the PROMIS domains of anxiety, depression, pain interference and physical function. A query was done to collect a group of patients that completed these four domains at two different office visits within one week. Patients were excluded if they were within 6 months from surgical intervention, had an acute trauma or had injection at the first visit as these would be expected to have variability within scores. Results A control group of patients with two visits with the same provider for the same orthopaedic complaint twice within the same week demonstrated no statistically significant difference between PROMIS scores in any of the four domains collected. A group of patients with two different primary orthopaedic complaints evaluated within the same week by two different providers demonstrated statistically significant differences between visits in anxiety and pain interference domains with improved scores at the second visit. Depression and physical function domains showed no statistically significant differences between visits for any group. For all four domains across all groups more than 20% of patients had scores that differed by at least half of a standard deviation (5 points). This was most profound in the anxiety domain with 38% of patients demonstrating more than a 5 point difference between visits and 13% demonstrating a full standard deviation difference between visits. Conclusions PROMIS-CAT domains of pain interference and anxiety may be less of a universal reflection of the patient's status within each domain than domains of physical function and depression which are more consistent across providers and primary complaints. 
This study was designed to determine if patient mental health and preoperative experience with pain could predict resource consumption postoperatively. Methods This retrospective cohort study evaluated all adult patients undergoing isolated unilateral (68%) or bilateral carpal tunnel release (32%) at a tertiary orthopaedic center from 6/1/2015-6/30/2016. All patients completed the PROMIS Pain Interference and Depression Computer Adaptive Testing (CATs) at their pre-operative visit. Postoperative encounters were quantified as a summation of postoperative office visits, phone calls, or electronic messaging related to their carpal tunnel syndrome. Pre-operative opioid use was determined by patient report and prescriptions recorded within 90 days preoperatively. Independent t-tests and chi square testing assessed the differences in initial PROMIS scores between the patients who had one versus more than one postoperative encounter as well as differences in age, sex, race, and opioid use between groups. Results 219 patients who underwent carpal tunnel release were eligible for the study. 59% of patients had a single postoperative encounter while 41% had multiple postoperative encounters (25% had two, 8% had three, and 8% required four or more). Patients who required multiple post-operative encounters had significantly higher preoperative PROMIS Depression scores (average difference 3 points, 95%CI 0.1-5.5). There was no difference in PROMIS Pain Interference scores or opioid use (each p>0.05). There was also no difference between the groups by unilateral versus bilateral surgery, average age, sex, or race (all p>0.05).
Conclusions
While depressive symptoms are thought to influence ultimate patient-reported outcomes, our data now indicate that greater depressive symptoms are also associated with more postoperative encounters after carpal tunnel release. If considering care within a bundled reimbursement model for carpal tunnel syndrome, preoperative PROMIS Depression scores may predict variability in postoperative resource consumption. general population-calibrated T-score metric. PROMIS Fatigue includes the FACIT-F items;scores on the scales are thereby interchangeable. Content debriefing FACIT-F identified 10 items relevant to RA patients. We assessed performance of these items and the 13-item FACIT-F using both crosswalk tables and the PROMIS scoring algorithm on data from 2 phase 3 baricitinib RA trials.
Methods
In RA-BEAM, methotrexate-inadequate responders were randomized 3:3:2 to placebo once daily (QD), baricitinib 4 mg QD, or adalimumab 40 mg biweekly (Taylor et al. NEJM.2017; 376:652-62) . In RA-BEACON, bDMARD-inadequate responders were randomized 1:1:1 to receive placebo or baricitinib 2 mg or 4 mg QD (Genovese et al. NEJM.2016; 374:1243-52 Background PROMIS has been used in rheumatoid arthritis (RA) patients (Pts). AWARE is a multi-center United States-based, real-world evidence study of patients initiating treatment with a Tumor Necrosis Factor inhibitor (TNFi; Simponi Aria or Remicade) in RA and utilizes PROMIS instruments and the Clinical Disease Activity Index (CDAI) to assess effectiveness. This analysis examined selected PROMIS measures to assess (1) relationship between baseline CDAI disease category and T-score, (2) PROMIS responsiveness after initiation of therapy and (3) relationship between T-scores of Profile29v2 Fatigue and Pain Interference questions and respective Short Forms (SF). Methods We report on TNFi pooled data from 1220 Pts' baseline PROMIS Pain Interference 6b (PI), Fatigue7a (F), Profile29v2 and CDAI. PROMIS Tscores were compared across CDAI levels of disease activity using ANOVA. We dichotomized pts on baseline T-score: P and F domains T-score >55 vs T-score </=55, and the Physical Function (PF) domain T-score <45 vs T-score >/=45. Data are mean ± standard deviation. Results Pts were 59.5±13.5 yrs, disease duration 8.2 ± 9.9 yrs, and baseline CDAI score 32.4±15.6. A significant relationship between PROMIS Tscores (PI, F) and baseline CDAI disease activity categories was confirmed. After starting therapy there was minimal change in T-score of pts with baseline PI and F T-scores </=55 and PF>/=45. Pts with baseline PI and F T-scores >55 and baseline PF T-scores <45 showed change from baseline. There was a significant (p<0.0001) relationship between PI and F T-scores and respective 4 questions on the P29v2. Conclusions We confirm validity of P measures according to CDAI disease category. In RA pts with P T-scores near normal, detecting change once pts start a TNFi therapy may be difficult. Pts with PI, F and PF Tscores >5 units from normal, demonstrated a robust T-score response to therapy. Keywords Rheumatoid Arthritis, TNF inhibitors, PROMIS-29, Physical Function, Pain Interference, Fatigue 
Background
The ECHO Program is a large-scale, transdisciplinary research consortium comprised of 84 extant pediatric cohorts. ECHO's Person Reported Outcomes (PRO) Core developed a measurement framework for assessing children's physical, mental and social health outcomes to complement exposure and biological biomarkers. This framework was the foundation for building the ECHO-wide new data collection protocol. An important step in this process was promoting the use of common measures or measures whose scores could be harmonized (e.g., scores could be linked to a common mathematical metric). Methods A survey was administered to representatives of each of the 84 cohorts. Respondents identified the measures they planned to use to target essential and recommended domains to be assessed in ECHO. The results were collated by domain across cohorts to identify which measures: 1) had already been harmonized (e.g., PROsetta Stone® cross-walks) and 2) would require primary data collection and application of harmonization methodologies. Results For some target domains, there was consistency in selected measures across cohorts. For other domains, a large number of measures were proposed, only some of which had sufficient evidence of harmonization. Others will require additional investigation to determine the feasibility of score harmonization. As an example, the ECHO Protocol recommends use of the PROMIS Depression scale to evaluate maternal depression, but cohorts proposed using 9 alternative measures, some of which do not have existing PROsetta Stone crosswalks.
Conclusions
The results of this study show both the promise and limits of measurement harmonization in large-scale research consortia. The ECHO research program benefits substantially from previous work conducted through PROsetta Stone; but to meet its goals, additional data collection and analyses will be needed to establish more score links to the PROMIS® metric. This study highlights both the recurring Background Many paediatric conditions present early in a child's life. Swedish quality registries wishing to apply PROMIS measures have requested proxy-reported outcome instruments for assessment of children from four years. The aim of this study was to identify proxy-reported items from established PROMIS measures that could be applied to children between the ages of four and eight years. Methods During a two-day quality review workshop at a Swedish university hospital, 15 health professionals from multiple professions in five teams and two linguistic experts examined 489 items in 19 paediatric item banks. Items considered suitable for proxy report for children under eight years were discussed and agreed within the teams. Results Forty percent of the items were judged to be suitable for use in the assessment of children from four years of age in proxy report. In total, 196 items were identified as suitable. There was variation within each item bank, ranging from no suitable items in the Life satisfaction and Meaning and purpose item banks to all items in the Physical stress item bank. In nine item banks, the majority of items (>50%) were thought to be suitable for younger children in proxy report.
Further work is required in order to confirm the suitability of the questions for younger children; this will be carried out in cognitive debriefing with parents during 2018. Criteria need to be established for the use of these banks in younger children. The calibration of the identified items will be examined to determine whether there is a need for further item development. The next stage of the project is to compare results across languages and to examine the statistical properties of the items. Focus will be on those item banks with greater than 50% of items judged to be appropriate for the younger age group. Keywords PROMIS, young children, proxy, self-report, Sweden 
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Background
To review the linguistic quality of the Swedish translation of child and adult PROMIS item banks. Methods Multidisciplinary review teams examined the linguistic quality of all Swedish PROMIS item translations. Teams reviewed the reconciliation, forward and backward translations and jointly agreed a final item version. Definitions from the Health Measures organization were used where available, as were item translations from NeuroQoL. Participants were encouraged to ensure that the translation was a conceptual equivalent to the English item and formulated so that it was grammatically and colloquially correct in Swedish. Results One child-item workshop with a total of five teams and five adultitem workshops with a total of ten teams were held between 2016 and 2018. More than 50 experts from all over Sweden participated, including medical doctors, psychologists, physiotherapists, dieticians, rehabilitation specialists, other health care professionals, patient representatives and linguistic experts. Age and experience varied from full-time professional to head of department. Between one and five teams of three to seven individuals were formed at each workshop.
Some experts participated in multiple workshops. Nineteen childitem banks (489 items) and 61 adult-items banks and short forms (781 items) were reviewed. The broad range of professions, nationalities and ages provided a comprehensive view of language usage. Participants quickly learned to work as a team, and gained familiarity with the linguistic requirements of the item formulation. Working on multiple item banks allowed comparison of word usage across banks. Teamwork sustained high levels of motivation throughout. Subjective concepts with multiple equivalent phrasing took longer to agree. Conclusions Improved item translations were achieved due to this multidisciplinary focus. The methodology and experience gained can be used as an example for other countries interested in translating PROMIS. The Swedish PROMIS items appear linguistically equivalent and ready for cognitive debriefing and cross-cultural validation. 
To evaluate the influence of recall periods on the assessment of physical function, we compared, in cancer and general population samples, the standard administration of PROMIS Physical Function items without a recall period to administrations with 24-hour and 7-day recall periods. Methods We administered 31 items from the PROMIS Physical Function v2.0 item bank to 2400 respondents (n=1,001 with cancer; n=1,399 from the general population). Respondents were randomly assigned to one of three recall conditions (24-hours, 7-days, or no recall) and one of two "reminder" conditions (with recall periods presented only before the first item or with every item). We tested recall and reminder effects with analysis of variance controlling for demographics, English fluency and comorbidities. Results Using analysis of variance, each condition was compared to the standard PROMIS administration for Physical Function (no recall period). There was no evidence of significant differences among groups in the cancer sample. In the general population sample, only the 24 hour recall condition with reminders was significantly different from the "no recall" PROMIS standard. At the item level, for both samples, the number of items with non-trivial effect size differences across conditions was minimal Conclusions For most experimental conditions, when compared to no recall, the use of a recall period has little to no effect upon PROMIS physical function responses or scores. We recommend that PROMIS Physical Function be administered with the standard PROMIS "no recall" period. Background A major barrier in the use of PROMIS® measures in clinical settings is the lack of an intuitive score interpretation framework. The objective of this study was to develop PRO T-Score Maps for interpreting PRO-MIS scores at the item level. Methods Using an R® program and based on the item parameters of calibrated item banks, we estimated most likely item responses by T-score level for 21 PROMIS item banks. These were used to create labeled heat maps for short form items that graphically display the most likely item responses across the measured score range. Results On the resulting PRO T-Score Maps, the PROMIS T-score metric is printed horizontally at the top of the page. Items and their response options are displayed in rows below. By tracking item responses with their locations on the T-score metric, users identify T-scores associated with each response across all levels of the domain assessed by the measure. The maps also allow interpretations of the clinical impact of score improvements. For example, for a patient who started with a score of 69 on the PROMIS® Depression measure, a 10 point score decrease would be improving from a probable report of feeling hopeless "often" to feeling hopeless "rarely".
Conclusions
The PRO T-Score Maps allow users to anchor T-score interpretations within a clinically intuitive context. These maps can be used to interpret both status and change scores and could inform clinical discussions about expectations for improvement and worsening. In the future, PRO T-Score Maps could be developed based on items selected by patients and clinicians. Such maps would anchor score interpretation in items that are most relevant to particular patients or clinical conditions. . A secondary data set that included responses to 6 of the 8 (PROMIS-MS-Fat6) items was analyzed to evaluate reliability and validity in advance of potential use in a clinical trial Methods N=594 individuals who had MS completed a survey as part of a longitudinal study of outcomes in MS. Available data included Expanded Disability Status Scale (EDSS) ratings and self-reported problems with symptoms. Also included were responses to PROMIS Global Health measure and clinical variables. Ten known groups analyses were conducted to compare mean PROMIS-MS-Fat6 T-scores of clinically meaningful groups: a) EDSS: <=4.5, >4.5, b) MS duration: <=5, >5 years, c) PROMIS Global Health, Physical Health, and Fatigue Values: excellent/very good/good vs fair/poor, d) PROMIS Physical Function T-Score of <=median score of 39.8 or > 39.8, 5) MS type: Relapsing Remitting (RRMS) or Progressive (PMS), and e) Spasticity, Imbalance, and f) Bowel/Bladder symptoms: not at all/a little or somewhat/quite a bit/very much. Reliability was assessed by calculating the range of scores in the sample for which reliability was ≥ 0.90. Ceiling and floor effects were defined as endorsing the highest/lowest response to all 6 items. Results All known groups analyses were statistically significant (p<.001). Reliability ≥ 0.90 was achieved for 91.3% of the full sample and 98.5% of those with T-scores ≥ 50. Ceiling effects in the clinical range of scores were minimal.
The results strongly support the validity of PROMIS-MS-Fat6 scores in distinguishing groups expected to have different levels of fatigue. Especially in the clinical range of scores (T-scores ≥ 50), reliability was high and floor/ceiling effects were low. These evaluations should be repeated in a dataset that includes responses to all 8 items of the PROMIS-MS. Background Light chain amyloidosis (AL) is a rare blood cancer wherein proteins made by malignant plasma cells misfold into amyloid fibrils and deposit in the heart, kidneys, nerves, etc. Patients are often diagnosed late and have high early mortality (30-40%) in the first year after diagnosis. The current standard-of-care using chemotherapy to eradicate the malignancy has no effect on pre-formed fibrils. Patientreported outcomes (PROs) have not been studied as endpoints in amyloid interventional trials. Methods In a phase 2 clinical trial studying doxycycline as an anti-fibril agent in in conjunction with chemotherapy (clinicaltrials.gov/ NCT02207556), the PROMIS Global Health Index was administered at baseline and monthly intervals during the study period. Patients were staged using the 2012 staging system. Results 31 patients were enrolled including 6 localized and 25 systemic AL. Baseline health was better in localized AL compared to systemic AL (Global Physical Health Score 48.7 vs 42.0; Global Mental Health Score, GMHS 51.3 vs 47.6, respectively) . Patients with advanced disease (stage III/IV) had higher GMHS at baseline compared to patients with early disease (stage I/II), 49.1 vs 45.9. Five patients with advanced stage AL died in the first year. In systemic AL, worsening of scores occurred in the first 3-6 months of treatment compared to baseline, likely related to the concurrent use of chemotherapy and known lag time before organ improvement. Both groups showed improvements in PROMIS scores from baseline to end of study.
Keywords
Conclusions
We report longitudinal PROs of AL patients enrolled on an interventional clinical trial. The PROMIS Global Health Index discriminated between groups as hypothesized by stage as well as over time with treatment. Counterintuitively, patients with advanced AL had higher PROMIS GMHS at diagnosis, which may represent relief at receiving a diagnosis for systemic symptoms present for a longer period. This finding needs further exploration. 
Methods
A cross-sectional analysis will be conducted on a non-clinical population of >600 adolescents drawn from junior and high-schools in northern Sweden. PROMIS Item banks translated into Swedish following the FACIT-trans method and the Swedish review workshop procedure will be used. The banks measure depression, anxiety, anger, positive affect, psychological stress, cognitive function, life satisfaction, meaning and purpose, fatigue, physical activity, pain interference, peer and family relationships.
Results
Ethics approval for the study has been given and data collection will start autumn 2018. We will use differential item functioning (DIF) analysis to evaluate parameter stability between the Swedish adolescent population and the US population; between genders and by age; we will also examine residual correlations to evaluate local dependence among Swedish items to compare against the US. Where possible correlation with other scales will be undertaken. The approach to the contact with schools and the use of an informed consent procedure with the parents will be described.
Conclusions
The identification and evaluation of item banks that can be used in a psychiatric population to measure constructs of health-related 
Methods
The Measuring Your Health Study administered all 7 PROMIS domains used in PROPr in a community-based sample (n=5506) of patients diagnosed with cancer, including a 6-month follow-up (n=2968, follow-up rate: 54%). We evaluated a linear regression model for predicting PROPr scores when cognitive function is missing by estimating the generalization error for patients at baseline, follow-up, as well as the ability to recover changes in the PROPr score for those measured at both baseline and follow-up. We evaluated out-of-sample prediction via root-mean-squared-error (RMSE) and mean error (ME).
Results
The RMSE (ME) for predicting PROPr scores at baseline is 0.056 (-0.013), on PROPr's -0.022 to 1 scale. The RMSE (ME) for predicting PROPr scores at follow-up is 0.059 (-0.014). The RMSE (ME) for predicting changes in the PROPr score is 0.060 (-0.0011 
Background
Existing researched has emphasized how coping strategies effect psychological well-being, but studies have failed to examine which specific coping behaviors are associated with high or low psychological well-being. In this study, we investigate the relationship between NIH Toolbox measures of psychological well-being and endorsement of primary coping behaviors in a large international internet-based sample. We hypothesized that greater psychological well-being would be associated with adaptive coping behaviors and that lower psychological well-being would be associated with maladaptive coping behaviors. Methods Utilizing a large web-based sample, we collected data from (N=26,770), participants through the data collection platform at SAPA-Project.org. Each participant endorsed one of nine coping behaviors, responded to subsets of items from two NIH Toolbox scales of Psychological Well-Being (General Life Satisfaction & Meaning and Purpose). To test our hypotheses, we analyzed the resulting dataset with tetrachoric and polychoric correlations between variables and scales. Results In testing our main hypothesis, we found that lower psychological well-being was associated with maladaptive coping behaviors, such that both General Life Satisfaction & Meaning and Purpose showed a negative or zero association with eating (r=-0.40, r=-0.14), substance use (r=-0.41, r=-0.57), ignoring stress (r=-0.02, r=-0.17), and distraction (r=-0.20, r=0.00). Additionally, high psychological well-being was associated with adaptive coping behaviors such that General Life Satisfaction & Meaning and Purpose showed a positive association with exercise (r=0.48, r=0.44), meditation/mindfulness (r=0.51, r=0.51), and spiritual practice (r=0.51, r=0.17). Conclusions Psychological well-being is an important construct that is associated with the selection of one's primary coping behavior. Background Quality of life is a complex construct influenced by sociodemographic, clinical and psycho-social factors. The Patient Reported Outcomes Measurement Information System (PROMIS) project has developed generalizable and universal PROMs. There has been little research to assess the relative contribution of clinical, sociodemographic and PROM variables to explaining health related quality of life (HRQOL) in advanced chronic kidney disease (CKD). Here we assess if adding PROMIS® domains will increase the explanatory power of models predicting HRQOL of patients with advanced CKD Methods This cross-sectional cohort study involved patients with advanced CKD (dialysis and post-transplant) recruited from two hospitals in Toronto. The depression, physical function, pain, sleep and fatigue domains of the PROMIS-57 questionnaire were completed electronically. Sociodemographic and clinical variables were collected from medical records. The EuroQoL (ED-5Q-5L) was used to measure of HRQOL. Linear regression models were fitted with expanding sets of co-variables to assess the contribution of the PROMIS domains on predicting HRQOL. Results Mean (SD) age of the 339 patients was 56 (17) years with 58% males and 50% Caucasians. The ED-5Q-5L scores ranged from 0.12 to 0.9. 
Each year approximately 30-40% of people over the age of 65 fall. Approximately one half of these falls result in an injury with the estimated annual direct medical costs of $30 billion. Identifying patients at risk to fall and implementing a prevention plan would help patients and save cost to the healthcare system. Methods Prospective PROMIS CAT physical function, pain interference, depression, fall risk assessment questions and patient demographics were collected for all patients at each clinic visit from an academic orthopaedic multi-specialty practice between January 2015 and November 2017. Standardized yes/no validated self-reported fall risk questions include: "Have you fallen in the last year?" and "Do you feel you are at risk of falling?" Histograms, t-tests, confidence intervals and effect size were used to determine the fall risk "YES" patients were different than the "NO" for ALL orthopaedic patients and specifically foot and ankle patients. Logistic Regression was used to determine if age, gender, height, weight, and PROMIS scales predicted self-reported falls risk. Results 94,761 orthopaedic patients comprising 315,273 visits (44% male, mean age 53.7+/-17 years) and 13,720 foot/ankle patients comprising 33,480 visits (37% male, mean age 52.7+/-16.1 years) had complete data for analysis. Although all PROMIS scores demonstrated significant impairment between patients at risk designation (yes/no), PRO-MIS PF had the largest effect size for ALL Ortho and FOOT AND ANKLE patients (0.8 and 0.7 respectively). Patients who are at risk to fall have PROMIS PF t-scores >1.5 lower than the United States normative population while the patients not at risk are less <1 SD. In the adjusted regression models gender and PROMIS PF had the largest coefficients. Conclusions PROMIS PF t-scores of <35 can be linked to self-reported fall risk. Many instruments that are used in mental health care are either inefficient and precise or efficient and imprecise, as they are based on classical test theory. To overcome this problem (among others), the Unites States PROMIS initiative has developed a set of instruments based on item response theory (IRT), using computerized adaptive testing (CAT). In the Netherlands, Dutch-Flemish CATs are validated using the PROMIS adult V1.0 item banks for Depression and Anxiety. The validation aspects concern both single measures and longitudinal measures, as well as comparisons of both groups and individuals. Methods First, cross-sectional data of the full item banks (N = 2010) was psychometrically evaluated using IRT (i.e., the Graded Response model; GRM) and Structural Equation Modelling (SEM). Second, data of the full item banks became recently available to evaluate longitudinal measurement invariance of the item banks using SEM (N = 500). Third, data is being collected to evaluate responsiveness of the CATs. Results The evaluation for cross-sectional use indicates excellent psychometric properties of the item banks. Furthermore, both item banks showed efficient and highly precise measurement applying a CAT simulation, and a similar accuracy between this CAT simulation and the full item bank administration. For the two studies concerning longitudinal measurement, we will present (preliminary) findings. Conclusions PROMIS offers assessment of patient-reported mental health -with an internationally applicable assessment battery -that is more efficient and precise than existing PROMs. Background Identifying patients at risk of not achieving minimally clinically important changes (MCICs) in PROMs after total joint arthroplasty (TJA) is important for better allocating resources toward monitoring patients and may aid in decision support. However, the ability of such predictive models to work across different PROMs, data sources, and time horizons is unknown. Methods We applied a machine learning (ML) algorithm, logistic LASSO, to hip and knee registry data from a high-volume facility to predict 2-year MCICs in SF-36 physical (PCSs) and mental component scores (MCSs). We derived models that incrementally incorporated information available: (1) before the decision to have surgery, (2) before surgery, (3) before discharge, and (4) after discharge. We evaluated performance with area under the receiver operating characteristic (AUROC) statistics using a hold-out sample of registry patients not used in model creation. We further tested whether these models could predict 6-month MCICs in PROMIS-10 PCSs and MCSs in a validation sample from our EMR. Results 12,203 registry patients had valid baseline and 2-year scores. AUROCs for predicting 2-year SF-36 PCS MCICs at the four time points were: 0.67, 0.74, 0.74, and 0.75. For MCS MCICs these were: 0.54, 0.88, 0.88, and 0.88. The EMR validation sample included 1,087 patients. Reusing the registry models, AUROCs for predicting patients' 6-month PROMIS-10 PCS MCICs at the four time points were: 0.56, 0.63, 0.63, and 0.65. For MCS MCICs these were: 0.50, 0.78, 0.78, and 0.79. Conclusions ML algorithms applied to registry data can predict 2-year postsurgical SF-36 PCS and MCS MCICs. Applying these models to EMR data to predict 6-month PROMIS-10 MCICs retains some, but not all, of their predictive power. Across PROMs, data sources, and time horizons, information available before surgery, namely baseline PROMs, yielded the largest gain in predictive power; including available postsurgical information yielded negligible improvement. A minimally important difference of 3 t-score units on PROMIS-PF corresponded cross-sectionally with differences across every HY stage and between fallers and nonfallers, and longitudinally with clinically meaningful declines on UPDRS total and motor scales. Differences over time among improvers on UPDRS were smaller than for decliners.
Conclusions
In a sample of PD patients, the PROMIS-PF had good concurrent validity in that it correlated well with other patient-and physician-rated scales cross-sectionally and longitudinally. A difference or change of 3 t-score units was able to distinguish between most clinically meaningful groups, especially with regard to decline or worse functioning. 
Background
The primary aim was to develop department-wide electronic data capture (EDC) of Patient Reported Outcome (PRO) measures at all ambulatory Orthopaedic clinical visits through a custom developed web-based application (WUPRO) that was minimally disruptive to existing clinical workflows. Secondary aims included the further integration of WUPRO with existing information technologies to support clinical and research applications reliant on PRO data. Methods A project manager and clinical administration developed a minimally invasive workflow for EDC. A cross-sectional team was brought together to review and help address identified barriers to implementation throughout the process. Technical development worked with an iterative approach that built, refined, and customized functionality throughout the implementation process. Daily meetings were used to address barriers and refine potential technical solutions.
Successful implementation was measured through the use of administrative reports. Amongst data reports, capture rate and completion rate were the primary markers for success. Results Implementation of PRO data capture via WUPRO was successfully achieved over a period of six months (6/22/15 -12/16/15). Department-wide capture rate at the conclusion of the implementation pilot was 99% and the completion rate was 99%. The patient population was generally accepting of the EDC system, with our patient population refusing to complete the assessments at 1.4% of visits. Two years after the initial pilot the department has maintained a capture rate of 99% and a completion rate of 95%. The refusal rate at visits is 1.2%. Conclusions Our implementation success was dependent on multiple factors including buy-in across all levels of the department, development of a flexible EDC system, and a collection process with a minimal footprint. Multidisciplinary meetings to go over implementation concerns as well as regular monitoring of staff performance provided support and allowed the implementation group to identify and address issues before they became significant barriers to data collection. Objective To describe the lessons learned from the implementation and early use of PRO data collection in the orthopaedic surgery department of an academic medical center.
Methods
The orthopaedic surgery department served as the pilot department for outpatient PRO collection. The implementation team introduced PRO data collection at 7 different clinical sites and each new launch allowed the team to refine technical and logistical procedures. Major technical obstacles were identified addressed by the implementation team prior to launch and minor obstacles were largely eliminated by the time full-scale departmental delivery of PRO assessments had begun. The implementation team, alongside appropriate clinical stakeholders, addressed any unforeseen issues that arose. Lessons learned were applied to future implementation sites. Results Provider and patient adoption of PRO data collection were among the most difficult hurdles to overcome for our department. Feedback received from clinical faculty and staff suggest that enhanced educational offerings would assist in preparing for implementation. Our patient populations provided feedback on specific modules (depression, anxiety) that indicated a lack of understanding how mental health impacts clinical healing. Conclusions Adoption of PRO assessment collection at our institution required significant support, both among our institutional executive committee and department level leadership. Despite this support, the major findings from our institutional pilots suggest that even more robust education for physicians, clinical support staff, and patients prior to implementation of PRO data collection is necessary in order to ensure smoother adoption. Technical hurdles offer another area of improvement, yet will vary by institution based on systems already in place and available resources. Our institution is in the process of deploying PRO collection in additional departments throughout the medical center. Critical lessons learned in the orthopaedic department were integral to honing the process of implementation and will assist future practitioners utilizing PRO data at our institution. Background The aim of this study was to examine the cross-cultural and construct validity of the Dutch-Flemish PROMIS ® Upper-extremity (UE) item bank v2.0 in a Dutch population of patients with musculoskeletal upper-extremity disorders. Methods Four PROMIS v2.0 physical function items, measuring upperextremity function, were translated into Dutch-Flemish. These items were combined with 42 already translated items, to develop the 46-item Dutch-Flemish PROMIS UE item bank v2.0. To examine validity, a cross-sectional design was used. Two hundred five patients referred to the Orthopedic Department of a general hospital in The Netherlands, aged 18 years or older, with musculoskeletal disorders of the upper extremity, were included between February and May 2018. Participants filled in a questionnaire with demographic and clinical characteristics, the DutchFlemish PROMIS UE item bank v2.0, and four legacy instruments. For cross cultural validity, Differential Item Functioning (DIF) was evaluated for language. For construct validity, a-priory hypotheses were tested for correlations with the legacy instruments. DIF was evaluated by ordinal logistic regression models. When items were flagged as potential DIF for language items, the impact of DIF was examined by plotting item characteristic curves and test characteristic curves. Correlations were quantified by Pearson's or Spearman's correlation coefficient. Results Eight items showed minimal DIF for language which resulted in sufficient cross-cultural validity. The Dutch-Flemish PROMIS UE item bank had a moderate correlation with the Dutch-Flemish PROMIS Pain Intensity item (r = -0.43) and strong correlations with the Disabilities of Arm, Shoulder and Hand Questionnaire (r = -0.87), the Functional Index of Hand OsteoArthritis (r = -0.86) and the Michigan Hand Outcomes Questionnaire (r = 0.81), all correlations were as hypothesized. To outline a protocol for the validation of the Swedish versions of the PROMIS global health scales and initiate the implementation of the scales in multiple clinical environments. Methods Adults and children and parents attending the Karolinska hospital together with a school-based sample of 'healthy normal' children will use an electronic data collection system to complete the GH-10 + EQ5D and the GH-9 + EQ5DY. Demographic and clinical data will be collected by an electronic records system (Take Care). Analyses will include the internal consistency and factor analysis. Reliability following a two-week test-retest procedure will be assessed. A differential function analysis will investigate if the items show signs of interaction with sample characteristics. Discriminant ability will be evaluated via known groups' analysis and responsiveness via before and after treatment evaluation.
Results
It is planned that a sample of 500 adults and 500 children/parents will be surveyed starting in 2019. The results of the study will indicate the statistical validity of the instruments and their clinical value in routine care. It is anticipated that the study will be able to identify different response patterns across diagnoses, gender, and age that will assist in the treatment process. Conclusions Before implementing the global health scales satisfactory statistical characteristics must be demonstrated; and they must be shown to be acceptable by both adults and children. Responsive to changes in condition and treatment change will be an important factor in the acceptance of the instrument for clinical routine use. However, it is vital that a methodology is identified for the implementation of the instruments within the clinical setting so that the results are used in routine clinical judgement. Key clinical sites within the hospital able to demonstrate clinical use will be targeted for the validation study thus encouraging hospital wide implementation. 
Methods
From a large data base 5499 unique patients with complete PASS and PROMIS data were identified. A total of 30.2% of patients attending a foot and ankle orthopedic service on the first available visit identified as PASS yes. Geocoding was used to estimate median income based on the 2010 US census. The sample average age was 52.3±16.4. The proportion of females was 63.6%; race was 85.9% White, 10.3% Black, and 1.9% were Asian and 2.9% other. Median income categories varied from Federal Poverty level(FPL) (<$24,999) to Upper Middle Class or higher (UMCOH) (>100K). PROMIS variables were converted to dichotomous variables using receiver operator curve analysis (PF>42, PI<56.2, Dep<47.8). Logistic regression models were explored to determine odds ratios (OR) for the best model to predict PASS. Results The highest OR was for PROMIS PI (4.02 95% confidence interval (CI) 3.45-4.67). The PROMIS Dep scale was also significant (1.31 95% CI 1.14-1.50), however, PROMIS PF was not significant (p=0.13). Income (0.88 95% CI 0.83-0.93) and race (1.15 95%CI 1.03-1.27) were also significant while gender (p=0.28) and age(p=0.17) were not. Conclusions The strongest predictor of PASS across variables was pain interference. While several other variables were also independent predictors of PASS, and significant, their OR were relatively close to 1, suggesting low clinical significance. 
Background
The minimal clinically important difference (MCID) is an important element of patient-reported outcome interpretation and it refers to the level of change that is considered meaningful from a patient or provider perspective. As yet there is little agreement on the best method for determining MCID. There is some evidence that condition type or disease severity does not greatly influence MCID levels. We applied comprehensive approaches to MCID estimation at multiple follow-up periods for sub-specialties of orthopaedics in foot, hand, and spine to determine various MCID values for the PatientReported Outcomes Measurement Information System (PROMIS) Physical Function (PF) and PROMIS Pain Interference (PI). Methods Consecutive patients aged 18 and older visiting a university orthopaedic center completed the PROMIS PF and PROMIS PI at first clinic visit and at follow-up visits. We estimated MCIDs using two distribution-based methods and two anchor-based methods at four follow-up periods. Patients were grouped based on level of change as indicated by a global rating of change measure used as the anchor question.
Results
The majority of MCID values from the different methods and followup points for the PROMIS PF ranged from 2-16 points in hand patients, 3-25 points in foot patients, and 3-20 points in spine patients. For majority of the PROMIS PI MCIDs ranged from 2-17 points for hand, 3-21 points for foot, and 1-21 for spine.
Conclusions
The smallest MCID values for each measure and specialty were obtained using 1/3 SD and ROC methods, and were all in the 2-3 point range regardless of orthopaedic specialty or follow-up time. The upper end of the MCID range showed more variability by specialty and patient type. MCID values at a mid-level of precision or lower are not likely to be impacted greatly by orthopaedic specialty, allowing similar MCID values to be applied across orthopaedic practice. Objective There are a number of joint or condition specific patient-reported outcome (PRO) measures used in orthopaedics. These PRO measures may be preferred for their ability to offer a brief and targeted assessment of the clinical area of interest. With the development of the Patient-Reported Outcomes Measurement Information System (PRO-MIS) Physical Function (PF) instrument and Computerized Adaptive Test (CAT) administration, it is possible to have a single instrument that can address the general needs of sub-specialties without a loss of precision and without added patient burden. The purpose of this study was to provide a crosswalk between the PROMIS PF and other commonly used PRO metrics in orthopaedics. Methods PRO instruments were delivered electronically to consecutive patients seeking care at an academic orthopaedic center between 2014 and 2017 at time of each visit as part of standard patient care. Linking was performed using graded-response IRT model and was used to transform the sub-specialty specific instrument scores into the PROMIS PF metric and to provide score conversion between these instruments. Results The PROMIS PF was correlated with the Foot and Ankle Ability Measure (FAAM) Activities of Daily Living (AD) subscale, the quick version of the Disabilities of the Hand and Shoulder (qDASH), and the Oswestry Disability Index (ODI).The measures were sufficiently unidimensional for IRT co-calibration. Crosswalk tables and mapping had been constructed to display the score linkage. Conclusions The development of crosswalks across new and previously used instruments encourages standardization of measurement, allowing the use of PROMIS CAT administration in future testing without a loss of data from previous patient testing. These crosswalks allow clinicians and patients, as well as researchers and administrators, the ability to interpret and understand the relationships between test scores and the ability to compare results from different studies. 
Background
To evaluate the ability of specific Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) items to discriminate levels of difficuly for four fundamental mobility tasks-sit-to-stand, bending, walking and stair climbing. Methods PROMIS PF 2.0 item model parameters were obtained. A subset of 33 items aligned with one of four International Classification of Functioning (ICF) mobility codes-Sitting (d4103), Bending (d4105), Walking (d450) or Climbing (d4551). Three items were selected for each code as best corresponding with one fundamental mobility task, while also scaling in increasing difficulty across a maximized range of T-scores. Selection was iterative, aligning model parameters for potential item triads with T-score ranges. A stacked column chart was generated to visualize scaling of item triads for clinical interpretation. Results Stair climbing scaled best, discriminating increasing difficulty ratings across three selected items for a T-score range of 35-53. The most difficult stair item had a "No Difficulty" rating threshold at a T-score of 61.5. Walking discriminated for a range of 35-48 ("No Difficulty" threshold 52.8). Bending discriminated for ranges 27-33 and 38-49 ("No Difficulty" threshold 57.7). For sit-to-stand, PF items were unable to discriminate increasing difficulty. Broadening ICF coding to Changing Body Position (d410) allowed selection of three PF transferring items (bed-to-chair, stand from armless chair, squat then stand) that discriminated well for a T-score range of 22-42 ("No Difficulty" threshold 49.8). Conclusions Four item triads from the PROMIS PF item bank best discriminated difficulty in four highly relevant fundamental mobility tasks. Available PROMIS PF sit-to-stand items scaled poorly, limiting linkage between T-score and patient improvement in this important mobility task. "No Difficulty" thresholds fell below the average US population T-score of 50 only for transferring. Clinicians may use scaling of these item triads to make direct connections between improvements in patient Tscore and physical abilities. Keywords PROMIS, T-Score, Physical Function, Physical Therapy, Mobility were used to calculate the area under the curve (AUC) for determining patients that were "Not Helped". Thresholds using 80% specificity were determined for patients "Not Helped". Results PROMIS PI(p<0.01), SESM(p<0.01), and SEDA(p=0.017) showed significant differences between Success responses for each category. However, PF was not significant (p=0.08). Both PROMIS PI(11.7, p<0.01) and SE(7.7, p<0.01) showed the largest differences between patients considered NH and PCoC with less distinct differences between NH and Imp categories for PI(6.5, P<0.01) and SESM(4.6, p=0.02). The AUC for PROMIS PF, PI, SESM, and SEDA were the highest for identifying patients NH, ranging from 0.66-0.76. The PROMIS thresholds were PF 41.0, PI 61.0, SESM 42.0 and SEDA 42.7. Conclusions PROMIS scales were successful at discriminating patients' judgement of Success after primary care treatment for musculoskeletal problems. The key predictors of patients "Not Helped" were PROMIS PI and SESM. The thresholds suggest benchmarks clinicians may use to judge when patients are likely not responsive to primary care MS treatment. Keywords PROMIS, Primary Care, Physical Therapy, Musculoskeletal, Multidimensional Assessment Objective When allocating a fixed amount of healthcare dollars, identifying the improvement surgery would provide is critical. Back pain patients are often thought to benefit less from surgery than other musculoskeletal patients as that they are more depressed, have less function and more pain. To evaluate the impact of lumbar discectomy (DSC) on patient-reported mood, function, and pain scores by comparing them to a matched cohort of patients undergoing arthroscopic anterior cruciate ligament reconstruction (ACLR). Methods Patients who underwent DSC or ACLR were retrospectively identified. PROMIS domains (PF, PI, Dep), patient demographics, and other encounter details were extracted. Primary outcomes (i) preoperative PROMIS domain scores and (ii) scores at a minimum of 40 days post-operatively for DSC patients and 133 days postoperatively for ACLR patients, and (iii) the change in scores with surgery. Propensity score matching identified age-, sex-, race-, and comorbidity-matched groups from each cohort. Chi-square tests and non-parametric Kruskal-Wallis tests compared the distribution of outcomes and characteristics. Multivariate linear regression models with interactions between the matched cohort and operative phase estimated the change in the outcomes scores between the two cohorts. Results 144 patients at a single academic medical center who underwent lumbar discectomy (n=88) or ACL reconstruction surgery (n=56) from February 2015 to July 2017 were identified. Age, gender, race, and Elixhauser co-morbidity index were similar between the matched cohorts (p>0.05). As compared to the ACLR cohort, the DSC cohort had lower adjusted post-operative PROM-PF scores (43.34 vs. 48.32) and higher adjusted post-operative PROMIS-PI (55.38 vs. 48.32) and PROMIS-D scores (46.2 vs. 39.2), indicating inferior outcomes. However, with respect to pre-operative scores, DSC patients experienced significantly greater improvement in PROMIS-PF (Adjusted estimate of interaction term: 3.35, 95% CI: 0.13 to 6.57, p=0.042). DSC patients experienced greater decline in PROMIS-PI (Adjusted estimate: -5.90, 95%CI: -9.14 to -2.66, p<0.001) and PROMIS-D scores (Adjusted estimate: -4.16, 95% CI: -7.60 to -0.72, p=0.018) with surgery.
The PROMIS standard for differential item functioning (DIF) has been hybrid logistic ordinal regression (i.e. lordif). However, several PRO-MIS banks have used other DIF procedures. It is common that different methods flag different items, without knowing which is correct. A simulation study allows direct evaluation of these procedures. Methods DIF was simulated under 14 different conditions in two hypothetical populations (28 simulations) for a 20-item fixed length test. DIF was simulated on 20% of items, varying type of DIF and focal population distribution differences with similar DIF-magnitude as previous studies (e.g. Woods, 2009). Items were flagged using five different methods. Errors (both over-and under-identification) were tracked, and generating theta score recovery was evaluated to gauge the impact of DIF on an individual's score.
Results
The Wald and lordif chi-square tests were most likely to correctly identify DIF items, but also over-identified non-DIF items. For the other methods, non-uniform DIF was rarely detected. Both lordif pseudo-R2 (i.e. the PROMIS standard method) and the weighted area between the curve (wABC; both potential "impact" as opposed to detection indices) also failed to detect some cases of uniform DIF. Examination of theta recovery suggested that using group-specific parameters only improved when there was also a difference in focal population distributions. Indeed, ignoring DIF items (both uniform and non-uniform) but modeling group-specific distributions provided adequate theta recovery in 86% of the simulations. Conclusions DIF detection procedures often produce different results. The PROMIS standard appears to under-identify non-uniform DIF, but so do many of the other procedures. Surprisingly, the impact of DIF on an individual's score was small even if item-level DIF was not included in scoring, provided that population differences were adequately accounted for. This has implications for PROMIS, where international researchers may detect language-based DIF and population differences from the US-based calibrations. Objective PROMIS CATs typically stop administering items after attaining a criterion score-precision level, currently set at standard error (SE) <3 (Tscore metric). This precision level provides scores with an approximate reliability of 0.91, appropriate for group-level score comparisons and single-time-point observations. Accommodating increasing interest in using PROMIS CATs to detect individual-level score change across time may require producing more precise scores. We investigated score precision benefits and response burden costs associated with increasing CAT score reliabilities from 0.91 to 0.95.
Methods
We used current item parameters from two banks (PROMIS Physical Function (PF)-165 items; PROMIS Depression (DEP)-28 items) to simulate CAT administrations for N=1000 cases (standard normal distribution). For each bank, we compared mean and median # of items administered, mean score SE, and the correlation between CAT vs. full bank scores, using maximum allowed CAT score SEs of 2.99 vs. 2.24 (T-score metric), reflecting score reliabilities of 0.91 and 0.95, respectively. Results For PF, when increasing score reliability from 0.91 to 0.95, mean # of items administered increased (5.31 to 6.80), median # of items increased (4.00 to 5.00), the CAT vs. full bank score correlation increased (0.976 to 0.982) and mean score SE decreased (2.48 to 2.23, T-score metric). For DEP, mean # of items administered increased (6.01 to 7.81), median # of items increased (4.00 to 7.00), the CAT vs. full bank score correlation increased (0.977 to 0.985) and mean score SE decreased (2.91 to 2.64). Conclusions Although statistically significant score differences may not be clinically meaningful, patient-or clinician-based meaningful score differences may not be implementable if scores are insufficiently precise. Modest increases in average CAT length (PF: +1.5 items; DEP: +1.8 items) contributed to improved score reliability and an improved ability to detect individual-level score change (95% T-score CIs: 0.91 reliability-± 5.88; 0.95 reliability-± 4.38). The aim of this research was to develop and validate a short form based on the PROMIS physical function (PF) item bank, for use in MS. Methods This research followed a mixed method approach and involved multiple stages.
P042
Step 1. Semi-structured concept elicitation (CE) interviews were carried out with patient with relapse-MS (n = 14 relapse-MS) from the US.
Step 2. Concepts identified from the CE interviews were mapped to the PROMIS PF item bank to generate an initial pool of MSrelevant items. Subsequently, a panel of neurologists (n =6) rated the relevance of the shortlisted items, in MS. Then, a panel of measurement experts, assimilated results from the CE interviews, the rankings from and the neurologist panel, with prior information about the PF item bank (i.e., item information functions), to optimize coverage of the PF continuum by the item pool.
Step 3. Cognitive debriefing (CD) interviews were carried out with MS patients (n = 24 relapse MS, n =24 primary progressive MS) from the US. Step 4. Two observational studies [cross-sectional study at two neurology clinics in the US, n = 300; and a longitudinal study based on the UK MS Register, n = 600] are being carried out to evaluate psychometric properties of the new short form. Results Eleven sub-domains relating to physical function (activities of daily living, upper-extremity, lower extremity functioning) were identified from the CE interviews [mean age = 44.1 years]. Initially, 48 items from the PROMIS physical function item bank matching concepts from the patient interviews were identified. Ratings by the neurologist expert panel (n =6) designated 38 items as the most relevant.
Subsequently, the measurement experts resolved content overlaps and optimized the draft measure for targeting and reliability across levels of physical function, resulting in a total of 26 items. CD interviews confirmed the comprehensibility and comprehension of the short form. Conclusions This research has demonstrated that the PF item bank comprehensively covers all concepts considered relevant for relapse and progressive MS. Moreover, the current approach took advantage of prior empirical evidence related to the item bank, which further facilitated optimal targeting of the new short form. Keywords PROMIS; Physical function; item response theory; multiple sclerosis; patient-reported outcomes 
Background
The accurate and efficient serial measurement of patient-centered outcomes is a priority in the clinical care of SLE. We aimed to evaluate the responsiveness of PROMIS10, a 10-item universal patientreported outcome measure of global physical and mental health, in SLE outpatients using patient and physician-derived anchors. Methods Adult SLE patients were recruited from an SLE Center of Excellence. Subjects completed PROMIS10 at two visits a minimum of one month apart. SLE disease activity was measured with a patient global assessment of change, a physician global assessment and the physician-derived SELENA-SLEDAI. Responsiveness over time of PRO-MIS10 scores was evaluated using known-groups validity. Effect sizes of changes in PROMIS global physical health and global mental health scores from baseline to follow up were compared across groups of patients who differed in their patient global assessment of change, physician global assessment, and SELENA-SLEDAI using Kruskal-Wallis tests. Results A diverse cohort of 223 SLE patients completed baseline surveys, with 186 (83%) completing a follow up survey. Using the patientbased anchor, PROMIS10 demonstrated mild to moderate responsiveness to improvement and worsening of health status for both global physical health (effect size 0.29, 0.0, and -0.27; p<0.001 for "better," "same," and "worse" health status respectively) and global mental health (effect size 0.29, 0.0, and -0.54; p<0.001). Using the physician-derived physician global assessment and SELENA-SLEDAI as anchors, there were no statistically significant differences in effect sizes across groups. Conclusions PROMIS10 showed responsiveness over time to patient-reported, but not physician-derived changes in lupus health status. These data suggest that PROMIS10 can be used to efficiently measure and monitor important aspects of the patient experience of lupus not captured by physician-derived metrics. Further studies are needed to evaluate the role of PROMIS in optimizing longitudinal disease management in SLE. 
Compare clinically important differences (CID) for PROMIS instruments (Physical Function(PF) and Pain Interference(PI)), and the Knee injury and Osteoarthritis Outcome Score (KOOS) using the established International Knee Documentation Committee (IKDC) scale as an anchor for change in subjects undergoing knee arthroscopy. Methods Patients undergoing knee arthroscopy at an ambulatory orthopaedic clinic were invited to participate. Subjects completed the PROMIS PF and PI instruments, KOOS and IKDC scales pre-operatively and postoperatively. Known minimal (11.5) and moderate (20.5) CID for IKDC improvement were used as anchor values. Receiver operator curve (ROC) analysis was applied to PROMIS and KOOS. Area under the curve (AUC) and thresholds that optimize sensitivity/specificity were used to compare PRO scales. Results 88 subjects having surgery for meniscus tears, synovial plica, chondromalacia, or a loose body were enrolled. Average age 48.6 (11.7), BMI 30.9 (6.7) and 55.4% male. The change from pre-operative to last available follow up (2 weeks to 12 months) provided a range of responses and expected improvement. The AUC values for minimal CID for PROMIS PF and PI were 0.88(0.04) and 0.85(0.04), respectively. This yielded minimal CID of 3.3 (PF) and 3.2 (PI). The AUC values for moderate CID in PROMIS PF was 0.86(0.04) and PI 0.89(0.04). This resulted in moderate CID of 5.2(PF) and -5.8(PI). The KOOS subscales AUC for minimal CID was 0.76 to 0.90. The KOOS subscales minimal CID ranged from 12.5 to 17.5. The moderate KOOS subscales AUC varied from 0.76 to 0.89. The KOOS subscales moderate CID ranged from 14.3 to 22.5.
Conclusions
The accuracy of the PROMIS and KOOS scales were comparable. Additionally, the CID for both minimal and moderate CID were comparable to other studies. This suggests that PROMIS scales are able to detect change in knee arthroscopy similarly or better as compared to well-established disease specific scales. Objective Cryptogenic sensory polyneuropathy (CSPN) is a common, progressive neuropathy presenting with significant pain. The study's objective was to determine which of four commonly prescribed medications is most effective and best tolerated. The study included continuous patient engagement to ensure meaningful outcomes were included in the design and analysis of findings.
Methods
We performed a prospective randomized open label comparative effectiveness study using a Bayesian adaptive design that included response adaptive randomization. At each interim analysis, a decision was made to either continue enrollment or stop the trial for success at baseline, weeks 4, 8 and 12. The primary outcome was a utility function which was a composite of efficacy and quits. 402 CSPN patients were randomized to nortriptyline (n=134), duloxetine (n=126), pregabalin (n=73), and mexiletine (n=69). Patients were asked during a focus group and via survey to identify patient-reported outcomes that should be used. Patients agreed with the investigator-selected choice of the PROMIS pain interference measure and suggested two additional PROMIS measures -fatigue and sleep interference. Results The utility functions were: nortriptyline 0.81 (95% credible interval 0.69-0.93, efficacy rates 25.4%, quit rates 38.1%); duloxetine 0.80 (95% credible interval is 0.68-0.92, efficacy rates 23.0%, quit rates was 37.3%); pregabalin 0.69 (95% credible interval 0.55-0.84, efficacy rates 15.1%, quit rates 42.5%), and mexiletine 0.58 (95% credible interval of 0.42-0.75, efficacy rates 20.3%, quit rates 58.0%). Patients reported the primary reason for discontinuing participation was side effects including dry mouth, nausea, insomnia and fatigue. Conclusion If patients could stay on medication for three months, mexiletine had the best improvement in pain and fatigue. While there was no clear winner when efficacy and quits are combined, overall nortriptyline and duloxetine outperformed pregabalin and mexiletine. Patient collaborators provided effective input on patient-reported outcomes that resulted in capturing side effects using the PROMIS measures. Keywords Neuropathy, Patient Engagement, Side Effects, Bayesian Adaptive Design.
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Does PROMIS
® Reflect Vocal Health Enough to Supplant Two Voice-Specific Quality of Life Instruments? Elliana Kirsh 1 , Thomas L. Carroll
Objective To evaluate disease-specific (VHI-10, SVHI-10) and general (PROMIS) health status in patients reporting voice dysfunction, and determine whether PROMIS data alone can accurately represent vocal health in this population. Methods Adults (n=734) presenting to a tertiary care academic medical center laryngology subspecialty clinic completed the Voice Handicap Index-10 (VHI-10) and the Patient-Reported Outcomes Measurement Information System, PROMIS) 10-item general health instrument. Patients reporting concerns about their singing voice also completed the Singing Voice Handicap Index-10 (SVHI-10) survey. Patient characteristics and distributions of instrument scores were determined. The Spearman rho statistic was calculated to test the null hypothesis that there were no correlations between the VHI-10 or SVHI-10 and PRO-MIS scores. The potential for crosswalks was also assessed.
Results
The mean VHI-10 and SVHI-10 scores were 12.9 (SD 10.7) and 24.9 (SD 8.6), respectively. Mean PROMIS T-scores were 48.7 (SD 9.5) for physical health and 51.2 (SD 9.8) for mental health. PROMIS scores were 3.4 (SD 1.0) for global health, and 3. The influence of mental health on patients' self-reported pain and function has not been explored using PROMIS in patients with symptomatic glenohumeral osteoarthritis. Methods This cross-sectional study included 284 shoulders in 276 patients presenting with isolated glenohumeral osteoarthritis at a tertiary center. All patients completed the American Shoulder and Elbow Surgeons (ASES) score, Simple Shoulder Test (SST), Visual Analog Pain Scale (VAS), and PROMIS computer adaptive tests (CAT) at the time of presentation. PROMIS Anxiety and Depression scores were converted into GAD-7 and PHQ-9 scores, respectively, using the PROsetta stone crosswalk. Mean pain and functional scores were compared between patients with and without PROMISconverted scores corresponding to a diagnosis of anxiety or depression, as well as between scores corresponding to varying severity of anxiety or depression. Results Compared to patients whose anxiety and depression scores were in the normal range, patients with PROMIS-converted scores corresponding to a diagnosis of anxiety or depression reported lower ASES, SST, Physical Function CAT (PFCAT), and Upper Extremity CAT (UECAT) scores and higher VAS and Pain Interference (PICAT) scores (p<.001). ANOVA analysis demonstrated lower overall ASES, functional ASES, SST, PFCAT, and UECAT scores as anxiety severity increased (p<.001). Similar results were seen with ASES and UECAT as depression severity increased (p<.001). Functional ASES (p=.004), SST (p=.001), and PFCAT (p=.002) were statistically significantly lower in those with moderate-to-severe depression. PICAT scores significantly increased as both anxiety and depression severity increased (p <.001 and <.01, respectively). Conclusions PROMIS-reported anxiety and depression scores correlate with lower functional and higher pain scores in patients with glenohumeral osteoarthritis. Further investigation is necessary to examine the influence that mental health has on outcomes following operative intervention in this population. Keywords Glenohumeral Arthritis, Shoulder, Outcomes, PROMIS, Depression, Anxiety, Function, Mental Health The objective of this analysis is to document the prevalance of patient acceptable symptom state (PASS) and determine the health domains that discriminate PASS patients and predict PASS state at the initiation of rehabilitation for foot and ankle problems. Methods Patient reported outcomes measurement information system (PRO-MIS) computer adaptive tests for physical function (PF), pain interference (PI), depression (Dep) and PASS ratings were identified from a large database. Of 746 unique patients, 114 patients had ICD-10 codes specific to the foot and ankle. Average age was 51(±18) years and 54.4% were female. ANOVA was used to evaluate differences in PROMIS scales by PASS state (Yes/No). The area under receiver operator curve (AUC) was used to determine the predictive ability of each PROMIS scale to determine PASS. Thresholds for near 95% specificity were also calculated for a PASS Yes state for each PROMIS scale.
The prevalance of PASS Yes patients was 13.2% (15/114). Pass Yes patients were significantly better by an average of 7.2 to 8.0 points across all PROMIS health domains compared to PASS No patients. ROC analysis suggested that Dep (AUC=0.73(0.07) p=0.005) was the highest predictor of PASS status followed by PI (AUC=0.70(0.08) p=0.012) and PF (AUC=0.69(0.07) p=0.18). The threshold PROMIS tscore values for determining PASS Yes with nearest 80% specificity were PF = 56.1, PI = 45.7, and Dep = 45.1. Conclusions A small but important subset of patients (13.2%) identify at their initial physical therapy consultation as at an acceptable level of activity and symptoms. The PROMIS thresholds suggest patients are identified by pain and physical function slightly lower than the US population (T-Score 50). Clinicians may adapt their care to reinforce these patients self efficacy, set goals appropriate to their PF and PI scores, and use this information to prevent unnecessary costly rehabilitatoin. (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) representative of the Dutch population on key demographics (age, sex, ethnicity and education level) were asked to complete the PROMIS Mobility, Upper Extremity and Pain Interference item banks (consisting of 24, 34 and 19 items respectively) and the Pediatric Quality of Life Inventory (PedsQL). The assumptions of unidimensionality (using CFA), local independence (residual correlations) and monotonicity (Mokken scale analysis) were assessed. DIF for gender was assessed. The item fit of the GRM model was assessed (S-X 2 , p-value > .001). High correlations (Pearson's r >.70) were expected between the PROMIS T-scores and the PedsQL Physical subscale. Weaker correlations (Δr >.10) were expected with other PedsQL subscales.
The final sample (n=555) was representative of the Dutch population (within 2.5%). The Mobility and Upper Extremity data was skewed. Unidimensionality was met for all item banks. Local dependence was present in the Mobility and Upper Extremity item banks (28 and 14 pairs, respectively). The assumptions of monotonicity were met. No DIF was found for gender and there was no item misfit. The Mobility item bank correlated highly (r=0.71) and the Pain Interference and Upper Extremity had a moderately strong correlation (r=-0.53, r=0.51, respectively) with the PedsQL Physical subscale. Pain Interference also had a moderately strong correlation with the PedsQL Emotional subscale (r=-.47). All other correlations were substantially weaker (Δr >.10).
Conclusions
The Dutch version of the pediatric Pain Interference, Mobility and Upper Extremity item banks displayed satisfactory psychometric properties In a Dutch normative sample. More data is required for estimating stable parameters, due to skewness. Higher difficulty items might be required for the Dutch population.
Background
Our aim was to validate the pediatric V2.0 PROMIS Peer Relationship item bank in a general Dutch pediatric population. Methods Children 8-18 years old (n = 1324), divided into two age groups (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) representative of the Dutch population on key demographics (age, sex, ethnicity, and education level), were asked to complete the PROMIS Peer Relationship item bank (15 items) and the Pediatric Quality of Life Inventory (PedsQL). The assumptions of unidimensionality (using CFA and bi-factor analysis), local independence (residual correlations) and monotonicity (Mokken scale analysis) were assessed. DIF was assessed for gender The item fit of the GRM model was assessed (S-X 2 , p-value > .001). For construct validity, high correlations (Pearson's r >.70) were expected between the Peer Relationship T-score and PedsQL Social subscale. Lower correlations (Δr >.10) were expected with the other subscales. Reliability of the full bank was calculated with the standard error of measurement (SEM) of theta.
Results
The final sample (n=527) was representative of the Dutch population (within 2.5% of population numbers). Unidimensionality was not conclusively met by CFA (CFI=.95, TLI=.94, RMSEA=.11), but was accepted after fitting a bi-factor model (omega H=0.88, ECV=0.81). The assumptions of monotonicity and local independence were met. No DIF was found for gender. One (reversed) item: "I played alone and kept to myself", displayed item misfit (S-X 2 (80)=140.11, p< .001)A moderate (r = 0.59) correlation was found between the item bank and the PedsQL Social subscale. Correlations with other subscales were substantially lower (Δr >.10). The SEM of the full-length item bank was satisfactory (< .32) for 87.6% of the patients. Ability estimates were most reliable in the direction of clinical interest. Background Chronic inflammatory demyelinating polyneuropathy (CIDP), is a rare condition involving neuromuscular disability which affects physical function and activity/participation. Methods Survey data from 475 US adults with self-reported CIDP, recruited by the GBS/CIDP Foundation, was used to evaluate diagnosis timing, treatment, and impact on (a) physical function measured using the PROMIS Physical Function (PF) Short Form-4 and (b) daily activity/participation measured using the Inflammatory Rasch-built Overall Disability Scale (I-RODS), containing activities ranging from 'easiest' (reading) to most 'difficult' (running). Patients were characterized by observed tertiles of PROMIS PF T-scores and I-RODS centile scores in terms of (a) time from initial symptoms to CIDP diagnosis and (b) impact on work/living conditions. Results Mean age at diagnosis: 51 years. Median time between first recognized symptoms and diagnosis: 7 months (>1 year for 39% of patients). PROMIS PF mean T-score was 37.0 (standard deviation [SD] = 8.4); tertiles: 23-33, 34-39, 40-57, compared with a US population norm of 50. I-RODS centile score was 57.4 (SD 17.5); tertiles: 6-47, 48-61, 63-100. Compared with the lower tertiles, patients in the 'best' tertile had a lower probability of: >12 vs. ≤12 months from initial symptoms to official diagnosis of CIDP 
Background
We would like to determine whether pre-operative PROMIS29 domains are associated with either serious adverse events or clinical outcomes 1-year after total hip or total knee replacement, (TKR and THR). Methods\Community-dwelling patients ≥65yo scheduled for elective TKR or THR were recruited from a musculoskeletal specialty hospital. PROMIS29 and Hip/Knee Injury and Osteoarthritis Outcome Score (HOOS/KOOS) were administered pre-operatively and at 1-year. Adverse events were obtained from medical records and by phone. Regression models were created by considering all variables which were significant at the 0.05 level in univariate models, and then performing backward selection to retain variables with 0.05 significance. Age and sex were forced in to all models. Results 740 subjects, 303 THR and 437 TKR enrolled. Mean age 72 years (range 65-94), 95.1% Caucasian, 63.5% female, and 9.0% had > 1 severe adverse event at 1 year. Controlling for age, gender, and which joint was replaced, pre-operative PROMIS29 pain intensity predicted being an OMERACT-OARSI responder at 1-year, (OR 1.6; 1.3-2.0). No PROMIS29 score predicted HOOS 1-year outcomes in THR. Among TKR, pre-operative PROMIS29 Fatigue was associated with 1-year KOOS Symptoms and Quality of Life scores, (p=0.02 and p<0.001), PROMIS29 Depression was associated with 1-Year KOOS Pain and Activities of Daily Living, (p=0.003 and p= 0.001). Pre-operative PRO-MIS29 Physical Function was also associated with KOOS 1-year ability to Perform Sport and Recreation, (p=0.002). In a multivariable regression, pre-operative PROMIS29 Depression scores were also significantly associated with 1-year SAE in THR cases, (OR 1.09; 1.02-1.17). Conclusions Multiple PROMIS29 domains predicted functional outcomes after TJR, including whether THR patients met OMERACT-OARSI responder criteria. Pre-operative PROMIS29 depression scores also predicted 1-year serious adverse events in THR. PROMIS29 may be an efficient tool to risk stratify this patient population in busy clinical practice. Objective To evaluate whether PROMIS-29 predicts short-term mental and physical health states after hip fracture surgery. Methods PROMIS-29 was administered to cognitively intact patients >65 years old, 2-4 days after surgery for low trauma hip fracture. Answers related to the week prior to fracture. Cumulative adverse events were measured through 30 days. PROMIS-29, Three-Item Loneliness Scale, Lubben Social Networks Scale (LSNS-18), and Falls Efficacy Scale (measures fear of falling) were administered at 3 months. Data analyzed using t-tests, Wilcoxon rank-sum tests, and Spearman correlations. Results 203 patients, 71.9% female, 91.6% Caucasian, median age 81.8. At 3 months. 4.8% died and 24.3% had > 1 serious adverse event (SAE). Patients who died had worse baseline PROMIS-29 Physical Function (34.4 vs 45.3; p=0.007) and trended towards worse PROMIS-29 Fatigue (43.1 vs.58.8; p=0.07). Patients with SAE had worse baseline Physical Function (38.5 vs. 48.0; p<0.001), Pain Interference (49.6 vs. 41.6; p=0.006), and Pain Intensity (3 vs. 0; p=0.002). Baseline PROMIS-29 Anxiety and Depression were correlated with PROMIS-29 Anxiety and Depression at 3 months (r=0.37 and r=0.41; both p<0.001). Baseline Anxiety and Depression were both strongly and significantly correlated with worse subjective loneliness at 3 months (r=0.52 and r=0.59; both p<0.001), but were not correlated with social isolation. In addition, baseline Depression, Anxiety, and Physical Function were strongly correlated with fear of falling at 3 months (r=0.46, r=0.40, r=-0.56; all p<0.001). Conclusions Baseline PROMIS-29 scores were associated with mental and physical health status after surgery for an unexpected hip fracture. They were also associated with fear of falling at 3 months, a strong predictor of future falls. Interestingly, PROMIS-29 scores were also associated with loneliness but not social isolation; loneliness is associated with incident frailty and worsening physical function. PROMIS-29 is a parsimonious instrument to effectively identify at-risk patients in this vulnerable population. Keywords PROMIS29, Arthroplasty, Osteoarthritis, Pain, Function 
To maintain high quality clinical collection of Patient-Reported Outcomes (PRO) it is important to develop a framework to support the acquisition of data. Methods Collecting PRO from thousands of patients a month is a great accomplishment, however, maintaining collections, adding new collection sites and keeping providers and staff informed is, arguably, as important as your collection platform. With input from physicians and staff we identified key areas to support ongoing collection of PRO.
Results
PROgram Initiation is where it begins as new sites are established. Integration between IT and the Program Manager is imperative to assure each site gets started with an effective and efficient collection scheme. PROgram Maintenance is a hands-on approach to reinforce lessons learned at initiation. Support is provided for all sites at scheduled intervals after initiation and as needed thereafter. To provide a culture of continuous learning, we PROmote Education for the providers, staff and patients. Understanding why the data is being collected and how it can be used results in invested participants. PROgram Monitoring is one of the most important components. It allows the PRO team, as well as providers and departments, to track process measures, including administration and completion rates. This information is also available to the Project Manager to identify potential problems that can be addressed before they result larger issues. Finally, the robust dataset produced by this successful collection process provides an opportunity to PRObe Data for quality improvement and research. Conclusions Developing a system that allows us to monitor and support PRO collections across the institution allows the 774 unique providers, who have collected data, to review the 1.8 million PRO scores, collected to date, on 204,086 unique patients. Continuous PROgram management maintains the momentum necessary for such a large enterprise to be successful at large-scale PRO collection and use. 
Guohua Li
Objective Research to address a potential association between negative driving outcomes and the broader concept of health-related quality of life (HRQOL) is needed. We hypothesize that individuals who report less driving space and more driving crashes will report a lower quality of life compared to those with positive driving outcomes. Methods This study uses baseline LongROAD data (prospective cohort with 2990 drivers aged 65-79 years). The outcome was the 8-domain PROMIS-29 Adult Profile. Multiple linear regression models calculated adjusted means for each of the PROMIS-29 outcomes by driving space and by crash status. We adjusted for demographics, vision, correct word recall, driving importance, days driven per week, miles driven per week and the standard errors by site. Results Participants with one or more crash had a higher adjusted mean or more pain for Pain Interference (47.8 (n=320)) compared to those with no self-report of crashes (46.3 (n=2460), P=0.275)). Participants with one or more crash had a higher adjusted mean or more pain for Pain Intensity. (2.22 (n=320)) compared to those with no selfreport of crashes (1.86 (n=2471), P=0.0064)). Participants with less driving space had a lower adjusted mean or less physical function for Physical Function (49.9 (n=622)) compared to those with a more self-reported driving space (51.2 (n=2160), P=0.0217)). Participants with less driving space also had a higher adjusted mean or more depressive symptoms for Depression (44.3 (n=626)) compared to those with a more self-reported driving space (43.6 (n=2173), P=0.0367)).
Conclusions
More crashes and less driving space were associated with more pain, less physical function and more depressive symptoms. These differences in the adjusted means were significant but not necessarily clinically meaningful. Besides impacting mental health (depressive symptoms), negative driving outcomes may also impact physical health (pain and function) with PROMIS-29 broadening the concept of HRQOL in driving research. Keywords Driving Space, Crashes, Older Drivers, PROMIS-29 
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Background
The purpose of this study is to evaluate the construct validity of five PROMIS measures in persons with and without mental disorders in Taiwan. Methods Three hundred and nine community sample, who did not report any mental illness conditions were recruited (mean age 27.8 ± 9.48 years). The subjects with mental disorders were recruited from mental health clinics and community based residential settings. Three hundred and twenty-two subjects with mental disorders (mean age 47 ± 11.5 years) were recruited from mental health clinics and community based residential settings (IRB approval, 201405051RINC). Thirty-five percent of the subjects were college graduates; Seventy-two percent of the subjects were single. The average self-rated quality of life score was 74. LISREL and SPSS were used for the subsequent analysis.
Results
The results showed that all scales presented excellent internal consistency with Cronbach's alpha value over 0.9 in the total. All items had a strong correlation with their own scale except some had mildly low item-total correlation (e.g. 0.4). The RWSEA, NFI, CFI, GFI, and AGFI of depression, anxiety, anger, sleep disturbance, and sleep related impairment scales were 0.11, 1.00, 1. 00, 0.99, 0.99; 0.11, 1.00, 1.00, 0.99, 0.99; 0.14, 1.00, 1.00, 0.97, 0.96; 0.16, 1.00, 1.00, 0.97, 0.97; 0.18, 1.00, 1.00, 0.96, 0.95 . There were significant differences on scores of anger, sleep disturbance and sleep related impairment scales between two groups which the healthy subjects had worse condition than persons with mental illness on anger and sleep related impairment. Conclusions The findings of this study supported the construct validity of depression, anxiety, anger, sleep disturbance and sleep related impairment scales. Further implication of the differences between healthy subjects and persons with mental illness on anger and sleep related impairment will be mentioned. For example, the Japanese translation of "in general" was revised to "usually." Some children commented that "health" and "physical health" were identical in meaning. The terms "rate," "quality of life" and "mood" required alternative translation solutions to ensure proper register for children, cultural appropriateness, conceptual equivalence and harmonization across languages. CAT-predicted PRO scores may be inaccurate when sources of heterogeneity (e.g., sex, age, health status) are ignored. The DraperLindley-de Finetti (DLD) framework of measurement validation provides a theoretical context for applying latent variable mixture models (LVMMs) for obtaining heterogeneity-adjusted CAT scores. Our objectives are to examine benefits and challenges of applying LVMMs to estimate heterogeneity-adjusted CAT scores and to compare them to unadjusted scores. Methods Data for our expository analysis were based on responses to 39 items of the daily activities domain of the CAT-5D-QOL. Respondents (N = 1,666) were recruited from a rheumatology clinic (20%), a waiting list for knee or hip replacement (20%), and a random stratified community sample (60%) in Canada. LVMMs were applied by specifying a mixture polytomous item response theory (IRT) model with difficulty and discrimination parameters free to vary across latent classes. The LVMM parameter estimates were used to program a "mixture-CAT" for obtaining scores that are adjusted for probability of class membership. Simulation was used to evaluate accuracy of scores. Results A 2-class LVMM resulted in improved model fit, relative to a 1-class model (class proportions were 0.64 and 0.36). Latent class membership was only partially predicted by several health status variables and age. Relative to a conventional CAT based on 1-class IRT parameter estimates (assuming no heterogeneity), a mixture-CAT based on the 2-class LVMM parameter estimates (accommodating population heterogeneity) resulted in improved accuracy. Conclusions Mixture-CATs could lead to improved accuracy of PRO scores in heterogeneous populations. Related benefits may include improved efficiency and diversity in item selection. However, these benefits rely on the ability to predict latent class membership, which could be a challenge. The results provide impetus for further research on mixture-CATs for measuring PROs. Keywords Computer adaptive test; latent variable mixture models; item response theory; population heterogeneity
Background
The PROMIS standard for differential item functioning (DIF) is hybrid logistic ordinal regression (with lordif in R); DIF analysis validates score comparability across languages. Methods To detect and evaluate language DIF, we subjected data in USEnglish (n=808), German (n=266), and Dutch (n=1995) for 19 commonly used PROMIS Physical Function items to iterative ordinal logistic regression, item response theory estimation/scoring, and Monte Carlo simulations in lordif. We first applied the conventional threshold of pseudo R 2 change (McFadden) = 0.02 (typically used in PRO-MIS analyses), as well as the Chi-square threshold (alpha = .01). In addition, we computed R 2 thresholds suggested by Monte Carlo simulations (1000 replications, alpha =.01) under no DIF assumptions. We repeated lordif runs, at small increasing thresholds of R 2 thresholds to examine which items consistently show the greatest overall DIF (uniform + non-uniform).
Results
No items were flagged for DIF with R 2 change of 0.02. The Chisquare threshold, however, flagged all items for DIF. The maximum R 2 value suggested by Monte Carlo simulations was 0.004; we re-ran the lordif function with incrementally higher R 2 thresholds, starting with 0.005 and increasing to 0.015. Five of the 19 items showed consistently higher resulting values for R 2 (> 0.01). These items showed mostly uniform DIF in the same direction, such that US participants were less likely to endorse items. The 4-item scale (PROMIS-29) contains two of these DIF items, while the 6-item scale (PROMIS-43) contains three. Language-specific location parameters were substantially different from one another (mean difference = .3 to .5). Conclusions We found preliminary evidence for consequential DIF. Small, uniform effect sizes (R2 ≈ 0.01) for two items can have a cumulative effect when the fixed-form is just 4-item long. 
Methods
In a large sample of patients with musculoskeletal complaints we studied the dimensionality by confirmatory factor analyses (CFA) and by assessing local independency. A bi-factor model was used to identify sub factors, and Omega-H and Explained Common Variance (ECV) were calculated to assess whether multidimensionality was likely to lead to biased parameters. A Graded Response Model was used to study item fit, and to estimate slope and threshold parameters.
Results
The dimensionality of the Pain Interference item bank was evaluated in a sample of 1677 patients. We found evidence of suboptimal unidimensionality in CFA (CFI: 0.903, TLI: 0.897, RSMEA: 0.144), and 99 item pairs with local dependence. A bi-factor model showed good fit (CFI: 0.964, TLI: 0.961, RSMEA: 0.089), with a high Omega-H (0.97), a high ECV (0.81), and no local dependence. The GRM showed good fit for all but two items, slope parameters ranged from 1.00 to 4.27, and threshold parameters ranged from -1.77 to 3.66. The dimensionality of the Pain behavior item bank was evaluated in a sample of 1602 patients. We found suboptimal evidence of unidimensionality in CFA (CFI: 0.816, TLI: 0.806, RSMEA: 0.093), and fifteen item pairs (2%) with local dependence. A bi-factor model showed better fit (CFI: 0.922, TLI: 0.915, RMSEA: 0.062), with a high Omega-H (0.92) and a high ECV (0.70). The GRM showed good item fit, slope parameters ranged from 0.60 to 2.00, and threshold parameters ranged from -2.05 to 6.80. 
Background
The evidence base for Patient-Reported Outcomes use post-stroke either fails to report or sufficiently evidence appropriate levels of acceptability. Primary research into the factors that most affect PROM completion post-stroke is required to address insufficient PROM acceptability and to enable the reporting of perceptions of health, quality of life or the outcomes of treatment by stroke survivors. Methods Phase 1 will recruit participants following acute admission for cerebral infarction or intracerebral haemorrhage. Baseline Assessment (14 Days or less Post-Stroke) consists of a stroke-specific cognitive screen the Oxford Cognitive Screen (OCS) and an ultra-brief Anxiety and Depression Screen the PHQ-4. At 90 to 120 Days Post-Stroke, participants will be rescreened using the OCS & PHQ-4 before participants attempt to self-complete the PROMIS-10. In Phase 2 participants unable to fully complete the PROMIS-10 will be re-screened utilising the PHQ-4 & OCS and randomised 1:1 to self-complete either the original PROMIS-10 or an 'Accessible' PROMIS-10. The design of the 'Accessible' PROMIS-10 will be derived from an analysis of the acceptability of the original PROMIS-10 in responding to cognitive, emotional, physical and socioeconomic factors. The 'Accessible' PROMIS-10 will feature adaptations to aid completion such as; visual analogue scales (VAS), pictorial representations, larger font and bolding/ italicisation of key words. The primary outcome of the study is PROMIS-10 completion rate (number who attempt versus number that 100% complete). This will be analysed using a Chi-square test of independence of the Original PROMIS-10 completion rate against the Accessible PROMIS-10 completion rate (Alpha 0.05 and Power 95%). Secondary outcomes such as completion rate per question and as a percentage of questions completed will be analysed utilising Logistic or Linear regression.
Results Conclusions
The study will provide evidence for which factors are related with the ability to complete PROMs post-stroke and will trial a method of addressing PROMs acceptability post-stroke. 
Background
The objective is to outline collection methods and clinical usage of PROMIS measures in the orthopaedic outpatient setting of an academic medical center. Methods The orthopaedic outpatient clinics of an academic medical center implemented the collection of PROMIS assessments in the summer of 2015. Orthopaedic faculty and midlevel providers were educated on the standard usage of PROMIS assessments and provided suggestions for adoption in clinical practice. Results Presently, PROMIS assessments are collected for the outpatient clinical visits of 60 orthopaedic faculty and 17 midlevel providers across 7 separate locations in a metropolitan area. PROMIS modules vary based on the population and the providers' subspecialty. Assessments are delivered in computer adaptive testing (CAT) format and results are delivered in real time to the electronic medical record (EMR).This allows clinical providers to view a patient's PROMIS score in the patient chart prior to the initiation of the patient visit. Pediatric PROMIS depression administration prompted parental complaints and resulted in our switch to delivery of pediatric peer relationships. Formal patient feedback regarding PROMIS scores has recently been delivered regarding adult Depression and Anxiety scores. Conclusions PROMIS has largely been incorporated into clinical practice successfully across practice locations. Depression CAT's selectively caused more complaints for pediatric visits and that assessment was then discontinued. At this time, clinicians indicate that they may review Physical Function scores but no thresholds or rules are followed to allow those scores to change treatment. Given the inter-relationship between physical and mental health, our clinicians have now formulated formal handouts for patients to address heightened Anxiety and/or Depression scores at the time of clinical care. Such response to mental health scores was delayed from the start of survey use as processes required development and responses were established with additional input from the University's Psychiatry Department and legal team. 
The primary aim is to describe the research output resulting from the implementation of routine PROMIS data collection in an academic orthopaedic surgery department. Methods The implementation of PRO data collection in the outpatient setting allowed for the collection of PROMIS assessments in computer adaptive testing (CAT) modules prior to patient visits. This informed the clinical decision making of the orthopaedic faculty but also introduced the capability to use that data to research orthopaedic conditions across subspecialties. Once approved by the local Institutional Review Board (IRB), our faculty were able to utilize PROMIS scores in research studies in specialized areas of focus. Results Presently, there are 5 peer reviewed journal articles in print resulting from our department's PROMIS data collection. There are an additional 10 research manuscripts either in process or submitted pending review. At present, there are 31 IRB approved studies investigating PROMIS measures in a variety of musculoskeletal conditions. Interest in PROMIS data collection and reporting also prompted the formation of a PROMIS study group within the department. This group's purpose is to share best practices in PRO related research methodology and statistical analysis.
Conclusions
The introduction of PROMIS data collection in the outpatient clinics at our institution increased the usage and reporting of research related findings in musculoskeletal injuries and conditions. Aided by an enthusiastic department chairman and widespread institutional support, our clinical faculty's interest in collecting and reporting PROMIS data has increased precipitously. The large demand for PRO data within research studies has also spurred further development of WUPRO to include greater research functionality. This functionality includes multiple methods of REDCap integration including direct data transfer to REDCap studies and integrating research forms alongside clinical data which will further increase our ability to leverage clinical PRO data collection to support research applications. 
Background
We aim to show how PROMIS item banks can be used to develop individualized short forms to measure more relevant outcomes for patients.
Methods
The effect of a new e-health intervention on return to normal activities was evaluated by a randomized controlled trial in 344 patients undergoing various types of abdominal surgery. Because "normal activities" is different for each patient, an individualized outcome measure was used. Participants were asked to select at baseline eight items from a pre-selected list of 29 items from the PROMIS V1.2 Physical Function item bank, which in their view most reflected their day-to-day activities. A T-score on the PROMIS metric was calculated for each patient based on their selected eight items. At follow-up patients completed the same eight items and indicated whether or not they had resumed these activities and if so, since when. The moment on which the last activity was resumed was the primary outcome of the trial. The T-score at follow-up (corrected for baseline) was the secondary outcome measure.
Results
Median time until return to normal activities was 5 days shorter for participants in the intervention group as compared to the control group (p=0.011). The mean physical function T-score was significantly higher at follow-up in the intervention group compared with the control group (0.024). Conclusions This is the first study that evaluated the effect of e-health on return to normal activities after abdominal surgery. Unique was the use of an individualized outcome measure, taking advantage of validated IRT-based item banks. Participants selected those activities that were most relevant for them in daily life and thus return to normal activities was specific to the outcomes that matter to participants. In addition, the selected activities matched the personalized e-health intervention. As a consequence, the effect of the intervention could be measured very specifically. 
Objective
To examine the feasibility of the Patient-Reported Outcomes Measurement Information System (PROMIS) in patients with various diagnoses in an outpatient rehabilitation setting. Methods Single centre pilot study, using PROMIS short forms collected online, including the PROMIS Ability to Participate in Social roles and activities (PROMIS-APS) and PROMIS Satisfaction with Participation in Social roles (PROMIS-SPS). These scales have a range from 0 to 100, where 50 depicts the average of the US population. Data were obtained at start of outpatient rehabilitation between April 12th 2017 and August 20th 2018 in the Rijnlands Rehabilitation Centre in Leiden, The Netherlands. Patients' age, diagnosis and sex were derived from electronic patient registries. Mean PROMIS-APS and SPS t-scores and SD were calculated and compared between diagnosis, age groups and gender using T-tests, One-Way Anova and multivariable regression analysis (GLM). Results 639 patients completed the electronic versions of the PROMIS-APS and SPS scales (no reminders sent, +/-50% response): 304 with acquired brain injury (Mean PROMIS-APS; PROMIS-SPS 43,0;41,6), 92 with neuro muscular diseases (43,4;43,0) , 88 with spinal and nerve injury (42,6;41,8) , 61 with musculoskeletal disease (42,1;41,2), 40 with organ rehabilitation (43,9;41,4), 29 with chronic pain (40,0;38,8) and 22 with amputation (43,2;39,3). Mean (±SD) age of participants was 55 years (±15), 321 (50%) were male. Mean (+SD) PROMIS-APS t-score was 42,8 (+7,5) and PROMIS-SPS 41,6 (+7,7). Sex was significantly associated with PROMIS-APS and with PROMIS-SPS t-scores. Differences in means between diagnosis were not significant.
Conclusion
The PROMIS-APS and PROMIS-SPS scales were successfully completed online by half of the patients admitted for outpatient rehabilitation, without sending reminders. The PROMIS-APS and PROMIS-SPS tscores were significantly lower than those of the US general population within all diagnosis groups. Preliminary data showing changes overtime will be presented. Background Acquisition, interpretation and dissemination of clinical data are driving change throughout the global healthcare market. Introduction of new regulatory requirements also places increased emphasis on the need to generate relevant clinical data. A digital platform to enhance patient engagement and collect patient-reported outcome measurements (PROMs) was recently adapted for TKA patients. A 4-month long feasibility study was initiated to gather feedback on the usability of this digital platform. Methods The digital platform consists of a patient mobile application (app) and a clinician dashboard. The app collects a variety of PROMs, including some based on the Patient-Reported Outcome Information System (PROMIS®). Additional features of the digital platform include staff-patient messaging, reminders and educational articles. Fifty-two patients (mean age 62.8 years, 56% females) were enrolled from 5 UK sites and 1 US site from January 12, 2018 to April 19, 2018. This work reports upon the results from this initial cohort of patients in terms of patient engagement and PROMIS® CAT surveys completion. Four PROMIS® domains were measured: Physical Function, Depression, Pain Interference and Pain Behaviour. Depending on their post-operative phase, a subset of patients additionally responded to surveys to assess app user experience.
Results
The patients demonstrated willingness to engage with the platform. On average, 83% of all enrolled patients engaged with the app at least once per week. Patients completed 77% of all PROMIS® CAT surveys during the considered timeframe, with similar survey completion rates regardless of the scoped PROMIS® CAT domain. Patients that completed the user experience questions responded a mean of 8.9/10 for the ease-of-use of the app (n=22). 9/13 patients were successful (7/10 or higher) at using the information from the app during their recovery.
Conclusions
The results so far collected show high patient engagement, app satisfaction and high adherence to the PROMIS® CAT survey completion. 
Methods
We used the static PROMIS-Emotional Distress fixed-length paperpencil self-administered short forms for depression (8 items) and anxiety (8 items) during consecutive outpatient oncology visits from 2013 through 2017. Forms were scored by the medical assistant during the patient visit, and provided to the clinician for review and follow-up, as indicated. Clinicians were notified that a raw score equivalent to a T-score > 55 (i.e. at least 0.5 SD higher than the mean) warrant attention. Results PROMIS forms were completed during 12,526 patient encounters, yielding 4,569 unique patients with at least one completed PROMIS assessment. Among these unique patients, 26% reported mild to severe distress. Among those who exhibited distress, 19% received an action of any type, as noted in the chart. Women who experienced mild to severe distress were significantly more likely to receive an action at 24% compared to their male counterparts at 12% (p < 0.000). Patients of color, specifically Hispanic and Asian patients, were more likely to report mild to severe distress (OR: 2.08 and 1.78 respectively, p < 0.000) even after adjusting for gender and age. Hispanic and Asian patients were also more than twice as likely to receive an action from providers given their scores (OR: 2.58 and 2.12 respectively, p < 0.000). Of the total providers, 33% administered actions when presented with informative distress trigger scores. Conclusions PROMIS emotional distress scores can provide meaningful prompts to action that address mental health concerns in the general oncology outpatient setting. Findings also highlight clinicians' capacity to address a racial/ethnic disparity in reporting distress among cancer patients. However, coaching, system-wide endorsement and electronic health record score integration is needed for these scores to be actively utilized. Keywords Emotional Distress, Depression, Anxiety, Oncology, Cancer, Outpatient, Action, Disparity Statistical analysis determined the effect of disparate area deprivation (based on most and least deprived national quartiles) for the entire population as well as patients categorized by the orthopaedic subspecialty providing care. Results Patients living in the most deprived quartile had significantly worse mean scores across all four PROMIS domains when compared to those living in the least deprived quartile, (p<0.01). Significant differences on PROMIS domains according to deprivation quartile was not evident for patients cared for by the Trauma, Oncology, and Spine divisions, where PROMIS scores indicated poorer physical and mental health than patients seeing other specialists. Background Patient-reported outcome (PRO) has become an emerging outcome in oncology practice. However, a little is known about health professionals' attitudes toward PRO and using experience. We aim to evaluate attitudes, experiences, and willingness to use of PRO among physicians and nurses work with cancer patients in Korea. Methods This is a cross-sectional survey conducted with 139 physicians and 71 nurses from August to September 2017 in Korea. Health professionals were recruited at the major cancer conference in Korea. Ten questions were asked to assess attitudes, knowledge, experience, and willingness to use the PRO for research and patient care. We also evaluated health professionals' needs and willingness to participate in education and training to learn about the assessment of PRO.
Conclusions
Results
Of total, 27.6% of the study participants said that they were exposed to the PRO and most of them learn about it from academic meetings or publication. Health professionals consider themselves that they do not have appropriate knowledge about the PRO (2.9 out of 10, 0=no knowledge, 10= high knowledge) and majority participants (73.8%) had intention to use PRO both for clinical care and research. In multivariate analysis, being nurse, specializing medical oncology, and working at academic institution were positively associated with experience with PRO. Most of the study participants (88.1%) have willingness to have education about PRO. Conclusions While oncology health professionals had limited experience, they had positive attitudes towards the PRO suggesting the needs of education and training for the health professionals. ) by integrating items specific to osteoarthritis of the knee (OA-K), thus facilitating comparisons to other conditions and the general population while enhancing OA-K sensitivity and clinical relevance.
Methods
Eight focus groups with OA-K patients (N=68) and phone interviews with clinicians (N=6) were conducted. Through an iterative process, existing items were reviewed, new items drafted, and items revised and cognitively tested (N=10 patients). In a cross-sectional sample of OA-K patients, we estimated reliability (internal consistency N=600; test-retest subsample N=100). We conducted convergent/divergent validity analyses using Pearson r and Spearman rho correlations with Knee Injury and Osteoarthritis Outcome Score (KOOS) subscores and known-groups validity testing with PROMIS Global Health (high vs. low Physical and Mental status). Measure responsiveness was tested via paired t-tests in a longitudinal sample of 238 OA-K patients pre-/ post-total knee replacement. Results PROMIS-Plus OA-K includes 76 items from 14 domains: 52 existing PROMIS items and 24 new OA-K-specific items. For cross-sectional analyses, internal consistency reliability (Cronbach's alpha) was 0.67-0.95, with alpha ≥0.70 in 10 of 12 domains. Test-retest reliability (intraclass correlation coefficients) were all ≥0.90. Correlations with KOOS subscores and PROMIS Global supported expected convergent (r/rho >0.60) and divergent validity (r/rho <0.30). We demonstrated known-groups validity with evidence of better health status in all PROMIS-Plus OA-K domains for high Global Physical and Mental status groups compared to low status groups. In our longitudinal sample, all PROMIS-Plus OA-K domains had statistically significantly (p<0.001) better health status scores at follow up vs. baseline.
Conclusions
The PROMIS-Plus OA-K Profile demonstrated good psychometric characteristics. The measure's enhanced relevance to OA-K patients may facilitate patient-centered care and research. Select domains can be administered, based on the preference and aims of the clinician, researcher and patient. 
Patients and Methods
Patients suffering from the degenerative joint disease (osteoarthritis of the knee, hip, and spine) were enrolled in the study. The translation from the English language to the Polish language, synthesis, back-translation, revision and cognitive testing were performed. Paper-and-pencil version of PROMIS Profile-29 v.2.0 (Polish version) was used. The test-retest the questionnaire was administered twice with 24-72 hours time interval. Data were analyzed with Scoring Service provided by Assessment Center (www.assessmentcenter.net), and PROMIS Wave 1 was chosen as a calibration sample. Each domain of PROMIS Profile-29 is scored individually. Physical Function, Pain Interference, and Depression domains were selected as the most relevant for orthopedic patients with the degenerative joint disease. Internal consistency of the translated questionnaire was tested by Cronbach's alpha, test-retest reliability was examined by the intraclass correlation coefficient (ICC). Results Ninety patients with the degenerative joint disease (osteoarthritis of the knee, hip, and spine) participated in a cross-sectional study at orthopedic and orthopedic rehabilitation outpatient clinics completed the Polish version of the PROMIS Profile-29 v.2.0. The group consisted of 39 men and 51 women. The average age was 66 years (34 ÷ 85 yrs; ± 12 yrs ). Women average age was 65 years (40 ÷ 83 yrs; ± 12 yrs ), men average age was 68 years (34 ÷ 85 yrs; ± 12 yrs ). Internal consistency tested by the Cronbach's alpha (0.82 -0.93) was good to excellent. The intra-class correlation coefficient was R = 0,90 (95% confidence interval: 0.04 -0,11).
Conclusion
The results showed that PROMIS Profile-29 v.2.0 (Polish version) is a valid tool to utilize among orthopedic patients with the degenerative joint disease. The measurement instrument has good to excellent reported test-retest reliability measured over durations of time ranging from 1 to 3 days. PROMIS Profile-29 v.2.0 (Polish version) is an effective tool to measure patient-reported outcomes and feasible to use in clinical trials in Poland. Keywords Orthopedic Patients, Musculoskeletal Disorsders, Degenerative Joint Disease, Osteoarthritis, PROMIS Profile-29 V.2.0 -Polish Version
